natgillin/translations-raw huggingface dataset:
This means that Bortezomib Sun is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Velcade.
To pomeni, da je podobno „referenčnemu zdravilu“, ki je že odobreno v Evropski uniji (EU), in sicer zdravilu Velcade.
This means that Busulfan Fresenius Kabi is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Busilvex.
To pomeni, da je podobno „referenčnemu zdravilu“, ki je že odobreno v Evropski uniji (EU), in sicer zdravilu Busilvex.
This means that cancer cells cannot divide and eventually die.
Posledica tega je, da se celice raka ne morejo razmnoževati in sčasoma odmrejo.
This means that Capecitabine SUN is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Xeloda.
To pomeni, da je podobno „referenčnemu zdravilu“, ki je že odobreno v Evropski uniji (EU), in sicer zdravilu Xeloda.
This means that Capecitabine Teva is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Xeloda.
To pomeni, da je podobno „referenčnemu zdravilu“, ki je že odobreno v Evropski uniji (EU), in sicer zdravilu Xeloda.
This means that Caspofungin Accord is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Cancidas.
To pomeni, da je podobno „referenčnemu zdravilu“, ki je že odobreno v Evropski uniji (EU), in sicer zdravilu Cancidas.
This means that Ciambra is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Alimta.
To pomeni, da je podobno „referenčnemu zdravilu“, ki je že odobreno v Evropski uniji (EU), in sicer zdravilu Alimta.
This means that Cinacalcet Mylan is similar to a ‘reference medicine’ already authorised in the European Union (EU).
To pomeni, da je podobno „referenčnemu zdravilu“, ki je že odobreno v Evropski uniji (EU), in sicer zdravilu Mimpara.
This means that clofarabine takes the place of adenine in the body, and interferes with the enzymes involved in making genetic material, called ‘DNA polymerase’ and ‘RNA reductase’.
To pomeni, da v telesu prevzame mesto adenina in ovira encima DNK polimerazo in RNK reduktazo, ki sodelujeta pri izgradnji genetskega materiala.
This means that Clopidogrel 1A Pharma is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Plavix.
To pomeni, da je zdravilo Clopidogrel 1A Pharma podobno „referenčnemu zdravilu“, ki je že odobreno v Evropski uniji (EU), in sicer zdravilu Plavix.
This means that Clopidogrel Acino is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Plavix.
To pomeni, da je podobno „referenčnemu zdravilu“, ki je že odobreno v Evropski uniji (EU), in sicer zdravilu Plavix.
This means that Clopidogrel Acino Pharma GmbH is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Plavix.
To pomeni, da je zdravilo Clopidogrel Acino Pharma GmbH podobno „referenčnemu zdravilu“, ki je že odobreno v Evropski uniji (EU), in sicer zdravilu Plavix.
This means that Clopidogrel Acino Pharma is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Plavix.
To pomeni, da je zdravilo Clopidogrel Acino Pharma podobno „referenčnemu zdravilu“, ki je že odobreno v Evropski uniji (EU), in sicer zdravilu Plavix.
This means that Clopidogrel Apotex is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Plavix.
To pomeni, da je podobno „referenčnemu zdravilu“, ki je že odobreno v Evropski uniji (EU), in sicer zdravilu Plavix.
This means that Clopidogrel BGR is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Plavix.
To pomeni, da je podobno „referenčnemu zdravilu“, ki je že odobreno v Evropski uniji (EU), in sicer zdravilu Plavix.
This means that Clopidogrel DURA is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Plavix.
To pomeni, da je zdravilo Clopidogrel DURA podobno „referenčnemu zdravilu“, ki je že odobreno v Evropski uniji (EU), in sicer zdravilu Plavix.
This means that Clopidogrel HCS is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Plavix.
To pomeni, da je podobno referenčnemu zdravilu, ki je že odobreno v Evropski uniji (EU), in sicer zdravilu Plavix.
This means that Clopidogrel Hexal is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Plavix.
„referenčnemu zdravilu“, ki je že odobreno v Evropski uniji (EU), in sicer zdravilu Plavix.
This means that Clopidogrel Krka is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Plavix.
To pomeni, da je zdravilo Clopidogrel Krka podobno „referenčnemu zdravilu“, ki je že odobreno v Evropski uniji (EU), in sicer zdravilu Plavix.
This means that Clopidogrel Qualimed is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Plavix.
To pomeni, da je zdravilo Clopidogrel Qualimed podobno „referenčnemu zdravilu“, ki je že odobreno v Evropski uniji (EU), in sicer zdravilu Plavix.
This means that Clopidogrel ratiopharm GmbH is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Plavix.
To pomeni, da je podobno „referenčnemu zdravilu“, ki je že odobreno v Evropski uniji (EU), in sicer zdravilu Plavix.
This means that Clopidogrel ratiopharm is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Plavix.
To pomeni, da je podobno „referenčnemu zdravilu“, ki je že odobreno v Evropski uniji (EU), in sicer zdravilu Plavix.
This means that Clopidogrel Sandoz is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Plavix.
„referenčnemu zdravilu“, ki je že odobreno v Evropski uniji (EU), in sicer zdravilu Plavix.
This means that Clopidogrel TAD is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Plavix.
To pomeni, da je podobno „referenčnemu zdravilu“, ki je že odobreno v Evropski uniji (EU), in sicer zdravilu Plavix.
This means that Clopidogrel Teva Pharma is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Plavix.
To pomeni, da je podobno „referenčnemu zdravilu“, ki je že odobreno v Evropski uniji (EU), in sicer zdravilu Plavix.
This means that darbepoetin alfa has a longer duration of action, and can be given less often than natural erythropoietin.
To pomeni, da ima daljši čas delovanja in se lahko daje manj pogosto kot naravni eritropoetin.
This means that Dasselta is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Aerius.
To pomeni, da je podobno „referenčnemu zdravilu“, ki je že odobreno v Evropski uniji (EU), in sicer zdravilu Aerius.
This means that Desloratadine Actavis is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Aerius.
To pomeni, da je podobno „referenčnemu zdravilu“, ki je že odobreno v Evropski uniji (EU), in sicer zdravilu Aerius.
This means that Desloratadine ratiopharm is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Aerius.
To pomeni, da je podobno „referenčnemu zdravilu“, ki je že odobreno v Evropski uniji (EU), in sicer zdravilu Aerius.
This means that Desloratadine Teva is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Aerius.
To pomeni, da je podobno „referenčnemu zdravilu“, ki je že odobreno v Evropski uniji (EU), in sicer zdravilu Aerius.
This means that Docefrez is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Taxotere.
To pomeni, da je podobno „referenčnemu zdravilu“, ki je že odobreno v Evropski uniji (EU), in sicer zdravilu Taxotere.
This means that Docetaxel Accord is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Taxotere.
To pomeni, da je podobno „referenčnemu zdravilu“, ki je že odobreno v Evropski uniji (EU), in sicer zdravilu Taxotere.
This means that Docetaxel Kabi is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Taxotere.
To pomeni, da je podobno „referenčnemu zdravilu“, ki je že odobreno v Evropski uniji (EU), in sicer zdravilu Taxotere.
This means that Docetaxel Mylan is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Taxotere.
To pomeni, da je podobno „referenčnemu zdravilu“, ki je že odobreno v Evropski uniji (EU), in sicer zdravilu Taxotere.
This means that Docetaxel Teva is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Taxotere.
To pomeni, da je podobno „referenčnemu zdravilu“, ki je že odobreno v Evropski uniji (EU), in sicer zdravilu Taxotere.
This means that Docetaxel Teva Pharma is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Taxotere.
To pomeni, da je podobno „referenčnemu zdravilu“, ki je že odobreno v Evropski uniji (EU), in sicer zdravilu Taxotere.
This means that due to scientific reasons it has been impossible to get complete information on this medicine.
To pomeni, da zaradi znanstvenih razlogov ni bilo mogoče pridobiti vseh podatkov o zdravilu.
This means that due to the lack of smallpox disease in the world it has not been possible to obtain complete information on this medicinal product.
To pomeni, da zaradi redkosti črnih koz v svetu ni bilo mogoče pridobiti vseh podatkov o zdravilu.
This means that due to the rarity of this disease it has not been possible to obtain complete information on this medicine.
To pomeni, da zaradi redkosti bolezni ni bilo mogoče pridobiti vseh podatkov o zdravilu.
This means that Duloxetine Mylan is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Cymbalta.
To pomeni, da je podobno „referenčnemu zdravilu“, ki je že odobreno v Evropski uniji (EU), in sicer zdravilu Cymbalta.
This means that Duloxetine Zentiva is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Cymbalta.
To pomeni, da je podobno „referenčnemu zdravilu“, ki je že odobreno v Evropski uniji (EU), in sicer zdravilu Cymbalta.
This means that Ebilfumin is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Tamiflu.
To pomeni, da je podobno „referenčnemu zdravilu“, ki je že odobreno v Evropski uniji (EU), in sicer zdravilu Tamiflu.
This means that Efavirenz Teva is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Sustiva.
To pomeni, da je podobno „referenčnemu zdravilu“, ki je že odobreno v Evropski uniji (EU), in sicer zdravilu Sustiva.
This means that Entacapone Teva is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Comtess.
To pomeni, da je podobno „referenčnemu zdravilu“, ki je že odobreno v Evropski uniji (EU), in sicer zdravilu Comtess.
This means that Envarsus is similar to a ‘reference medicine’ that contains the same active substance but Envarsus has been formulated in a different way and is available at different doses.
To pomeni, da je podobno „referenčnemu zdravilu“, ki vsebuje isto zdravilno učinkovino, vendar pa je bilo zdravilo Envarsus izdelano na drugačen način in je na voljo v drugačnih odmerkih.
This means that Enyglid is similar to a ‘reference medicine’ already authorised in the European Union (EU) called NovoNorm.
To pomeni, da je podobno „referenčnemu zdravilu“, ki je že odobreno v Evropski uniji (EU), in sicer zdravilu NovoNorm.
This means that Epoetin Alfa Hexal is similar to and contains the same active substance as a biological medicine that is already authorised in the European Union (EU), which is known as the ‘reference medicine’.
To pomeni, da je podobno biološkemu zdravilu, ki je v Evropski uniji (EU) že odobreno in vsebuje isto zdravilno učinkovino, ter je znano kot
This means that Eptifibatide Accord is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Integrilin.
To pomeni, da je podobno „referenčnemu zdravilu“, ki je že odobreno v Evropski uniji (EU), in sicer zdravilu Integrilin.
This means that Filgrastim Hexal is similar to a biological medicine that is already authorised in the European Union (EU) and contains the same active substance (also known as the ‘reference medicine’).
To pomeni, da je podobno biološkemu zdravilu, ki je že odobreno v Evropski uniji (EU) in vsebuje enako zdravilno učinkovino (imenovano tudi „referenčno zdravilo“).
This means that Filgrastim ratiopharm is similar to a biological medicine that is already authorised in the European Union (EU) and contains the same active substance (also known as the ‘reference medicine’).
To pomeni, da je zdravilo Filgrastim ratiopharm podobno biološkemu zdravilu, ki je že odobreno v Evropski uniji (EU) in vsebujejo enako zdravilno učinkovino (t.i. „referenčno zdravilo“).
This means that Flixabi is similar to a biological medicine (also known as the ‘reference medicine’) that is already authorised in the European Union (EU).
To pomeni, da je podobno biološkemu zdravilu (t.i. „referenčnemu zdravilu“), ki je že odobreno v Evropski uniji (EU).
This means that for scientific reasons it has been impossible to get complete information on this medicine.
To pomeni, da zaradi znanstvenih razlogov ni bilo mogoče pridobiti celotnih informacij o tem cepivu.
This means that for scientific reasons it has not been possible to obtain complete information on this medicinal product.
To pomeni, da iz znanstvenih razlogov ni bilo mogoče pridobiti vseh podatkov o zdravilu.
This means that for scientific reasons, it has not been possible to obtain complete information on this medicinal product.
To pomeni, da iz znanstvenih razlogov ni bilo mogoče pridobiti vseh podatkov o cepivu.
This means that further evidence on this medicinal product is awaited, in particular about Fampyra’s benefits beyond its effects on walking speed and with respect to early identification of responders.
To pomeni, da se pričakujejo dodatni dokazi o zdravilu, zlasti o drugih koristih zdravila Fampyra poleg učinka na hitrost hoje, in o zgodnji identifikaciji oseb, ki se odzivajo.
This means that further evidence on this medicinal product is awaited.
To pomeni, da se pričakujejo dodatni dokazi o cepivu.
This means that Glidipion is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Actos.
To pomeni, da je podobno „referenčnemu zdravilu“, ki je že odobreno v Evropski uniji (EU), in sicer zdravilu Actos.
This means that Grepid is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Plavix.
To pomeni, da je podobno „referenčnemu zdravilu“, ki je že odobreno v Evropski uniji (EU), in sicer zdravilu Plavix.
This means that Iasibon is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Bondronat.
To pomeni, da je podobno „referenčnemu zdravilu“, ki je že odobreno v Evropski uniji (EU), in sicer zdravilu Bondronat.
This means that Ibandronic Acid Sandoz is similar to a ‘reference medicine’ already authorised in the European Union (EU).
To pomeni, da je podobno „referenčnemu zdravilu“, ki je že odobreno v Evropski uniji (EU).
This means that Ibandronic Acid Teva is similar to a ‘reference medicine’ already authorised in the European Union (EU).
To pomeni, da je podobno referenčnemu zdravilu, ki je že odobreno v Evropski uniji (EU).
This means that Ifirmacombi is similar to a ‘reference medicine’ already authorised in the European Union (EU) called CoAprovel.
To pomeni, da je podobno „referenčnemu zdravilu“, ki je že odobreno v Evropski uniji (EU), in sicer zdravilu CoAprovel.
This means that Ifirmasta is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Aprovel.
To pomeni, da je podobno „referenčnemu zdravilu“, ki je že odobreno v Evropski uniji (EU), in sicer zdravilu Aprovel.
This means that Imatinib Accord is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Glivec.
To pomeni, da je podobno „referenčnemu zdravilu“, ki je že odobreno v Evropski uniji (EU), in sicer zdravilu Glivec.
This means that Imatinib Actavis is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Glivec.
To pomeni, da je podobno „referenčnemu zdravilu“, ki je že odobreno v Evropski uniji (EU), in sicer zdravilu Glivec.
This means that Imatinib medac is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Glivec.
To pomeni, da je podobno „referenčnemu zdravilu“, ki je že odobreno v Evropski uniji (EU), in sicer zdravilu Glivec.
This means that Imatinib Teva is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Glivec.
To pomeni, da je podobno „referenčnemu zdravilu“, ki je že odobreno v Evropski uniji (EU), in sicer zdravilu Glivec.
This means that Inflacam is similar to a ‘reference medicine’ already authorised in the EU called Metacam.
To pomeni, da je podobno referenčnemu zdravilu, ki je že odobreno v Evropski uniji (EU), in sicer zdravilu Metacam.
This means that Inflectra is similar to a biological medicine (the ‘reference medicine’) that is already authorised in the European Union (EU) and that Inflectra and the reference medicine contain the same active substance.
To pomeni, da je podobno biološkemu zdravilu („referenčnemu zdravilu“), ki je že odobreno v Evropski uniji (EU), in vsebuje isto zdravilno učinkovino kot referenčno zdravilo.
This means that Inhixa is highly similar to a biological medicine (also known as the ‘reference medicine’) that is already authorised in the European Union (EU).
To pomeni, da je zelo podobno biološkemu zdravilu (t. i. „referenčnemu zdravilu“), ki je že odobreno v Evropski uniji (EU).
This means that Irbesartan Teva is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Aprovel.
To pomeni, da je podobno „referenčnemu zdravilu“, ki je že odobreno v Evropski uniji (EU), in sicer zdravilu Aprovel.
This means that Irbesartan/Hydrochlorothiazide Teva is similar to a ‘reference medicine’ already authorised in the European Union (EU) called CoAprovel.
To pomeni, da je podobno „referenčnemu zdravilu“, ki je že odobreno v Evropski uniji (EU), in sicer zdravilu CoAprovel.
This means that it activates a type of receptor called the ‘peroxisome proliferator-activated receptor alpha’ (PPAR), which is involved in breaking down fats from diet, especially triglycerides.
To pomeni, da aktivira vrsto receptorja, imenovanega „s peroksisomskim proliferatorjem aktiviran receptor tipa alfa“ (PPAR), ki sodeluje pri razgradnji maščob iz hrane, še zlasti trigliceridov.
This means that it acts in the same way as incretins (hormones produced in the gut) by increasing the amount of insulin released by the pancreas in response to food.
To pomeni, da deluje na enak način kot inkretini (hormoni, proizvedeni v črevesu), in sicer s povečevanjem količine insulina, ki ga sprošča trebušna slinavka ob odzivu na hrano.
This means that it affects the activity of the immune system (the body’s natural defences).
To pomeni, da vpliva na delovanje imunskega sistema (naravnega obrambnega mehanizma telesa).
This means that it alters the activity of the immune system (the body’s natural defences).
To pomeni, da spremeni aktivnost imunskega sistema (naravnega obrambnega mehanizma telesa).
This means that it attaches to a specific type of opioid receptor called the ‘mu-opioid receptor’ and blocks opioids from binding to these receptors.
To pomeni, da se veže na določeno vrsto opioidnega receptorja, ki se imenuje „mu- opioidni receptor“, in blokira vezavo opioidov na te receptorje.
This means that it attaches to opioid receptors and acts like the body’s natural opioids to calm down waves of contractions along the digestive system.
To pomeni, da se veže na opioidne receptorje in se obnaša kot naravni opioid v telesu, da pomiri valove krčev v prebavnem sistemu.
This means that it attaches to the muscle relaxants rocuronium and vecuronium forming a ‘complex’ that inactivates the muscle relaxants and stops them having an effect.
To pomeni, da se veže na mišična relaksanta rokuronij in vekuronij ter tako tvori „kompleks“, ki inaktivira mišične relaksante in jim prepreči, da bi učinkovali še naprej.
This means that it blocks a specific type of opioid receptor called the ‘mu-opioid receptor’.
To pomeni, da zavira posebno vrsto opioidnih receptorjev, imenovanih mu-opioidni receptorji.
This means that it blocks the action of a group of proteins known as ‘ErbB family’ which are found on the surface of cancer cells and are involved in stimulating the cells to divide.
To pomeni, da zavira delovanje posebne družine beljakovin, imenovane „družina ErbB“, ki so na površini rakavih celic in sodelujejo pri spodbujanju nenadzorovane delitve celic.
This means that it blocks the activity of enzymes known as tyrosine kinases.
To pomeni, da zavira dejavnost encimov, znanih kot tirozin kinaze.
This means that it blocks the activity of enzymes known as tyrosine kinases.
To pomeni, da zavira določene encime, imenovane tirozin kinaze.
This means that it blocks the proteasome, which is a system within the cells that breaks down proteins when they are no longer needed.
To pomeni, da zavira proteasom, tj. sistem v celicah, ki razgrajuje beljakovine, ko te niso več potrebne.
This means that it has not been possible to obtain complete information about Bluevac BTV8.
To pomeni, da o zdravilu Bluevac BTV8 ni bilo mogoče pridobiti vseh informacij.
This means that it is converted into amfenac in the eye.
To pomeni, da se šele v očesu pretvori v amfenak.
This means that it is converted to aprepitant in the body.
To pomeni, da se v aprepitant pretvori v telesu.
This means that it is essentially “sodium-free”.
To pomeni, da je bistvu “brez natrija”.
This means that it is made by cells that have received a gene (DNA), which makes them able to produce the human interferon.
To pomeni, da je izdelan iz celic, ki so prejele gen (DNK), kar jim omogoča proizvajanje humanega interferona.
This means that it is similar to a ‘reference medicine’ (in this case Lantarel FS) containing the same active substance (methotrexate).
To pomeni, da je podobno „referenčnemu zdravilu“ (v tem primeru zdravilu Lantarel FS), ki vsebuje isto zdravilno učinkovino (metotreksat).
This means that it is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Rebetol.
To pomeni, da je podobno „referenčnemu zdravilu“, ki je že odobreno v Evropski uniji (EU), in sicer zdravilu Rebetol.
This means that it is similar to a ‘reference medicine’ already authorised in the European Union (EU), called Kaletra.
To pomeni, da je podobno „referenčnemu zdravilu“, ki je že odobreno v Evropski uniji (EU), in sicer zdravilu Kaletra.
This means that it is similar to a ‘reference medicine’ containing the same active substance, but given in a different way.
To pomeni, da je podobno „referenčnemu zdravilu“, ki vsebuje isto zdravilno učinkovino, vendar se jemlje na drugačen način.
This means that it is similar to a ‘reference medicine’ containing the same active substance, but Pheburane granules are available at a lower strength and contain different excipients (inactive ingredients) to mask the unpleasant taste of the active substance.
To pomeni, da je podobno referenčnemu zdravilu, ki vsebuje enako zdravilno učinkovino, vendar so zrnca zdravila Pheburane na voljo v nižji jakosti in vsebujejo drugačne pomožne snovi (nedejavne sestavine), da prekrijejo neprijeten okus zdravilne učinkovine.
This means that it is similar to a ‘reference medicine’ containing the same active substance, but Procysbi is available in a formulation that allows for a delayed release of the active substance in the body.
To pomeni, da je podobno „referenčnemu zdravilu“, ki vsebuje isto zdravilno učinkovino, vendar pa je zdravilo Procysbi na voljo v obliki pripravka, ki omogoča zapoznelo sproščanje zdravilne učinkovine v telesu.